Atara Biotherapeutics (ATRA) Work In Process (2022 - 2024)

Atara Biotherapeutics has reported Work In Process for 3 years, with the latest figure at $9.7 million in Q4 2024.

• For the quarter ending Q4 2024, Work In Process rose 31.47% year-over-year to $9.7 million; the trailing twelve-month figure through Dec 2024 stood at $9.7 million (up 31.47% YoY), and the FY2024 full-year result was $9.7 million, up 31.47% from the prior year.
• Work In Process for Q4 2024 stood at $9.7 million, down from $12.3 million in the prior quarter.
• The five-year high for Work In Process was $15.1 million in Q2 2024, with the low at $372000.0 in Q4 2022.
• Historically, Work In Process has averaged $7.8 million across 3 years, with a median of $7.4 million in 2023.
• Annual changes were most pronounced in 2023 — Work In Process surged 1881.45% — and 2024, when it jumped 31.47%.
• Atara Biotherapeutics' Work In Process stood at $372000.0 in 2022, then surged by 1881.45% to $7.4 million in 2023, then jumped by 31.47% to $9.7 million in 2024.
• The last three Work In Process figures came in at $9.7 million (Q4 2024), $12.3 million (Q3 2024), and $15.1 million (Q2 2024), per Business Quant data.